期刊文献+

冠状动脉多支血管病变和慢性完全闭塞性病变对急性ST段抬高型心肌梗死患者住院期间预后的影响 被引量:7

Impact of multivessel disease and chronic total occlusion on in-hospital outcome in acute ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention
下载PDF
导出
摘要 目的探讨非梗死相关血管(non-IRA)发生管腔狭窄或慢性完全闭塞性病变(CTO)对急性ST段抬高型心肌梗死(STEMI)患者住院期间预后的影响。方法回顾性分析345例连续入院接受急诊经皮冠状动脉介入治疗(PPCI)的急性STEMI患者的临床资料,根据是否存在冠状动脉多支血管病变或CTO病变进行分组,比较各分组间患者的临床特征、PPCI资料、住院期预后和并发症情况,并采用多因素分析确定住院期间发生主要心血管不良事件(MACE)的独立危险因素。结果 345例急性STEMI患者中共有185例(53.6%)存在冠状动脉多支血管病变,其中110例(31.9%)为双支血管病变,75例(21.7%)为三支血管病变。冠状动脉多支血管病变中合并CTO病变20例(10.8%),占同期PPCI总量的5.8%(20/345)。多支血管病变患者的年龄显著大于单支血管病变患者(P<0.01),原发性高血压、心源性休克、植入≥2枚药物洗脱支架患者的构成比均显著高于单支血管病变患者(P值均<0.05),与单支血管病变患者间梗死相关血管(IRA)构成的差异有统计学意义(P<0.01)。合并CTO病变患者的心力衰竭构成比显著高于不合并CTO病变患者(P<0.05),左心室射血分数显著低于不合并CTO病变患者(P<0.01),与不合并CTO病变患者间术后心肌梗死溶栓试验(TIMI)血流分级构成比的差异有统计学意义(P<0.05)。在住院期间总体患者的MACE发生率为10.4%(36/345),病死率为8.1%(28/345),大出血并发症发生率为1.2%(4/345)。单支血管病变与多支血管病变患者间病死率、再发心肌梗死率、靶血管血运重建率、脑卒中发生率、MACE发生率、大出血发生率的差异均无统计学意义(P值均>0.05),合并CTO病变患者的靶血管血运重建率和MACE发生率均显著高于不合并CTO病变患者(P值均<0.05)。单因素分析结果显示,在住院期间发生MACE的患者中年龄≥75岁、发生心源性休克、发生心力衰竭、术后TIMI血流分级<3级、合并 Objective To assess the impact of multivessel disease and chronic total occlusion (CTO) on in-hospital outcome in aculte ST-elevation myocardial infarction (STEMI) patients undergoing primary percutaneouscoronary intervention (PPCI). Methods This is a retrospective observational study of 345 acute STEMI patients. Clinical and angiographic characteristics were compared between patients with and without multivessel disease as well as CTO lesion. Logistic regression analysis was applied to the identify the independent risk factors of in- hospital major adverse cardiac events (MACE). Results There were 185 patients (53.6%) with multivessel disease, including 110 (31.9%) with double vessel disease and 75 (21.7%) with triple vessel disease. CTO lesion was complicated in 20 patients with multivessel disease (5.8 %, 20/345). Patients with multivessel disease were significantly older and more likely to have hypertension, cardiogenic shock, more stents (at least 2) and more difference in infarction related artery (IRA) location than those with single vessel disease (P〈0. 01 or 0.05). Patients with coexisting CTO had lower left ventricular ejection fraction (LVEF) and higher incidence of heart failure, and were less likely to achieve thrombolysis in myocardial infarction (TIMI) 3 flow in the IRA post- procedural (P〈0.0t or 0.05). The total incidence of in-hospital MACE was 10.4% (36/345), case fatality was 8.1% (28/345) and hemorrhea incidence was 1. 2%. There were no significant differences in terms of case fatality, incidence of recurrent myocardial infarction, target vessel revascularization, stroke, MACE or hemorrhea between patients with multivessel disease and single vessel disease (all P〉0. 05). The incidence of target vessel revascularization and MACE in the patients with CTO lesion was significantly higher than that in the patients without CTO lesion (P 〈 0. 05). Univariate analysis showed that the patients suffering from in-hospital MA
出处 《上海医学》 CAS CSCD 北大核心 2015年第3期199-204,共6页 Shanghai Medical Journal
基金 国家973项目(2006CB503803) 国家863项目(2006AA02A406)资助
关键词 急性ST段抬高型心肌梗死 急诊经皮冠状动脉介入治疗 慢性完全闭塞性病变 预后 Acute ST.elevation myocardial infarction~ Primary percutaneous coronary intervention^Chronic total occlusion~ Prognosis
  • 相关文献

参考文献13

  • 1JASKI BE, COHENJ D, TRAUSCHJ, et al. Outcome of urgent percutaneous transluminal coronary angioplasty in acute myocardial infarction: comparison of single-vessel versus multi vessel coronary artery disease] I}. Am HeartJ, 1992, 124(6): 1427-1433. 被引量:1
  • 2SHIHARA M, TSUTSUI H, TSUCHIHASHI M, et al. In-hospital and one-year outcomes for patients undergoing percutaneous coronary intervention for acute myocardial infarction[J]. AmJ Cardiol , 2002, 90(9): 932-936. 被引量:1
  • 3MORENO R, CONDE C, PEREZ- VIZCA YNO MJ, et al. Prognostic impact of a chronic occlusion in a noninfarct vessel in patients with acute myocardial infarction and multivessel disease undergoing primary percutaneous coronary intervention[J].J Invasive Cardiol , 2006, 18(1): 16-19. 被引量:1
  • 4VAN DER SCHAAF RJ, VIS M M, SJAUW K D, et al. Impact of multi vessel coronary disease on long-term mortality in patients with ST-elevation myocardial infarction is due to the presence of a chronic total occlusion[J]. AmJ Cardiol , 2006, 98(9): 1165-1169. 被引量:1
  • 5SORAJ JA p, GERSH BJ, COX D A, et al. Impact of multi vessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction[J]. Eur HeartJ, 2007. 28(14): 1709-1716. 被引量:1
  • 6KIMJ v .JEONG M H. AHN Y K. et al. Decreased glomerular filtration rate is an independent predictor of in-hospital mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention[J]. Korean CircJ. 2011, 41( 4): 184- 190. 被引量:1
  • 7MOZID AM. MOHDNAZRI S. MANNAKKARA N N. et al. Impact of a chronic total occlusion in a non-infarct related artery on clinical outcomes following primary percutaneous intervention in acute ST-elevation myocardial infarction[J].J Invasive Cardiol , 2014. 26(1): 13-16. 被引量:1
  • 8潘洪涛,高鹏,王旭渤,刘忠岐.急性ST段抬高心肌梗死合并非梗死相关动脉慢性完全闭塞直接PCI预后观察[J].中国临床研究,2011,24(11):972-974. 被引量:3
  • 9LEE C W. PARK S W. CHO G v , et al. Pressure-derived fractional collateral blood flow: a primary determinant of left ventricular recovery after reperfused acute myocardial infarction[J].J Am Coll Cardiol , 2000, 35(4): 949-955. 被引量:1
  • 10ANTONIUCCI D, VALENTI R, MOSCHI G, et al. Relation between preintervention angiographic evidence of coronary collateral circulation and clinical and angiographic outcomes after primary angioplasty or stenting for acute myocardial infarction[J]. AmJ Cardiol, 2002, 89(2): 121- 125. 被引量:1

二级参考文献16

  • 1霍勇,洪涛.经皮冠状动脉介入技术是当前治疗急性冠状动脉综合征的重要手段[J].中华心血管病杂志,2006,34(6):481-482. 被引量:10
  • 2徐立,杨新春,王乐丰,葛永贵,王红石,李惟铭,倪祝华,刘宇,崔亮.提前应用替罗非班对急性ST段抬高心肌梗死患者急诊介入治疗疗效的影响[J].中华心血管病杂志,2006,34(11):983-986. 被引量:48
  • 3KEELEY E C, BOURA J A, GRINES C L. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials [J]. Lancet, 2003, 361:13-20. 被引量:1
  • 4VAI.GIMIGI.I M, PERCOCO G, CICCHITEI.LI G, et al. High dose bolus tirofiban and sirolimus eluting stent versus abiciximab and bare metal stent in acute myocardial infarction (STRATEGY)study-protocol design and demography of the first 100 patients [J]. Cardiowlsc Drugs Ther, 2004, 18= 225 230. 被引量:1
  • 5A clinical trial comparing primary coronary angioplasty withtissue plasminogen activator for acute myocardial infarction. The Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO 1I b) Angioplasty Substudy Investigators [J]. N Engl J Med, 1997, 336:1621-1628. 被引量:1
  • 6KARVOUNI E, KATRI'FSIS D G, I()ANN1D1S J P. Intravenous glycoprotein Ⅱb/Ⅲa receptor antagonists reduce mortality after percutaneous coronary interventions [J]. J Am Coil Cardiol, 2003, 41: 26-32. 被引量:1
  • 7EMREA, UCER E, YESILCIMEN K, ct al. Impact of early tirofiban administration on myocardial salvage in patients with acute myocardial infarction undergoing infarct related artery stenting [J]. Cardiology, 2006, 106:264 269. 被引量:1
  • 8MARTINEZ-RIOS M A, ROSAS M, GONZALEZ H, et al. Comparison of reperfusion regimens with or without tirofihan in ST-elevation acute myocardial infarction [J]. Am j Cardiol, 2004, 93: 280-287. 被引量:1
  • 9CHEN Z M, J1ANG L X, CHEN Y P, et al. Addition of clopidogrel to aspirin in ,15,852 patients with acute myocardial infarction: randomised placebo controlled trial[J]. i.ancet, 2005, 366:1607- 1621. 被引量:1
  • 10Serruys PW, Ong AT, Morice MC, et al. Arterial Revascularization Therapies Study Part II-Sirolimus-eluting stents for the treatment of patients with multivessel de novo coronary artery lesions [J]. Eurointervention,2005, 1(2) : 147 - 156. 被引量:1

共引文献5

同被引文献49

引证文献7

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部